□ 搜 索
关键字
  
Nature Medicine:β-连环蛋白稳定表达可延长调节性T细胞寿命
发布时间2008年2月25日11时23分

  

  美国纽约大学医学院Ding等在《自然医学》杂志上报道,β-连环蛋白(Beta-catenin)稳定表达可延长调节性T细胞(regulatory  T  cell)寿命。

  Wnt
通路的组成主要包括:细胞外因子Wnt、跨膜受体卷曲蛋白、散乱蛋白、结肠腺瘤样息肉病基因产物、β-连环蛋白及T细胞因子/淋巴样增强因子等一系列蛋白。

  β-
连环蛋白是Wnt通路的关键分子。在体外试验中,CD4+CD25+调节性T细胞稳定表达β-连环蛋白,可显著延长细胞寿命。在炎症性肠病治疗中,若CD4+CD25+调节性T细胞稳定表达β-连环蛋白,则可以保留必要的调节性T细胞起到保护作用,而非一味地控制T细胞数量。对于非调节性T细胞(CD4+CD25-  T细胞、Foxp3-缺陷  T细胞)而言,稳定表达β-连环蛋白可诱导其不应答。

  所以,研究人员认为,通过延长调节性T细胞寿命和诱导T效应细胞前体不应答,β-连环蛋白将对炎症性疾病的预防产生重要影响。(医学空间)

生物谷推荐原始出处:

Nature Medicine14, 162 - 169 (2008)
Published online: 3 February 2008 |doi:10.1038/nm1707

Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells

Yi Ding1,2, Shiqian Shen1, Andreia C Lino1, Maria A Curotto de Lafaille1,3 & Juan J Lafaille1,3

Abstract

-catenin is a central molecule in the Wnt pathway. Expression of a stable form of -catenin on CD4+CD25+ regulatory T (Treg) cells resulted in a marked enhancement of survival of these cells in vitro. Furthermore, stable -catenin–expressing CD4+CD25+ Treg cells outcompeted control Treg cells in vivo, and the number of Treg cells necessary for protection against inflammatory bowel disease could be substantially reduced when stable -catenin–expressing CD4+CD25+ Treg cells were used instead of control Treg cells. Expression of stable -catenin on potentially pathogenic CD4+CD25- T cells rendered these cells anergic, and the -catenin–mediated induction of anergy occurred even in Foxp3-deficient T cells. Thus, through enhanced survival of existing regulatory T cells, and through induction of unresponsiveness in precursors of T effector cells, -catenin stabilization has a powerful effect on the prevention of inflammatory disease.

1.                            Molecular Pathogenesis Program and Skirball Institute for Biomolecular Medicine, New York University School of Medicine, 540 First Avenue, New York, New York 10016, USA.

2.                            Sackler Institute of Graduate Biomedical Sciences, New York University School of Medicine, 540 First Avenue, New York, New York 10016, USA.

3.                            Department of Pathology, New York University School of Medicine, 540 First Avenue, New York, New York 10016, USA.

Correspondence to: Juan J Lafaille1,3 e-mail: lafaille@saturn.med.nyu.edu

 

                                                          摘自《生物谷》

 
【查看评论】 【发表评论】 【关闭窗口】
 
 相关链接
NIAID签署5100万美元研究合同 构建免疫反应综合模型2007-11-28 11:05:00
CDD:王缨和熊思东教授发现CD4+CD25+ 调节性T细胞免…2007-11-20 10:52:00
脱乙酰基酶抑制可增强调节T细胞的抑制功能2007-10-11 11:45:00
JCI:人体对HIV-2病毒的免疫应答有助艾滋病疫苗研发2007-9-25 11:07:00
Nature:华人教授解析免疫学突破性进展2007-8-2 11:56:00
免疫细胞不足引发多发性硬化症2007-7-31 11:20:00
美国科学家发现一种治疗肠毒素B感染新方法2007-6-1 10:55:00
备受关注的靶向B细胞治疗2007-5-18 12:58:00
TAT-BH4能降低辐射后的细胞死亡率2007-5-18 12:54:00
我国超级抗原抗癌应用居国际领先地位2007-5-17 11:17:00